BRENNEN POPLUS: Open Payments
NPI 1760836746 · LA PLACE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 43 payments from 5 companies in 2025. Trend: 2023 $1,058 · 2024 $934 · 2025 $942
Food & beverage: $942
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 15 | $375 |
| Alkermes, Inc. | 10 | $200 |
| Otsuka America Pharmaceutical, Inc. | 9 | $191 |
| E.R. Squibb & Sons, L.L.C. | 5 | $100 |
| Lundbeck LLC | 4 | $76 |
Products named: INGREZZA, ABILIFY ASIMTUFII, ARISTADA, COBENFY, ABILIFY MAINTENA.
Industry payments across LA — which companies pay providers there.
